Discussion on the comorbidities and management of tuberculosis in China

doi:10.3969/j.issn.1000-6621.2021.06.005

Abstract

Abstract:

With the increase of coexisting diseases in tuberculosis patients, comorbidities of tuberculosis have attracted more attention. Researches on comorbidities are no lack in China, but the concept of comorbidity is rarely used in the field of tuberculosis, the management of comorbidity between tuberculosis and other diseases needs more improvement. The expression and use of comorbidity, and the role and significance of tuberculosis and comorbidities management were summarized to further explore the related problems.

Key words: Tuberculosis, Comorbidity, Concept, Epidemics, Disease management

CHEN Qiu-qi, DENG Guo-fang. Discussion on the comorbidities and management of tuberculosis in China[J]. Chinese Journal of Antituberculosis, 2021, 43(6): 546-549. doi: 10.3969/j.issn.1000-6621.2021.06.005

References 33

[1]	周玉洁, 吕启圆, 李现文. 共病及共病指数研究进展与应用展望. 中国公共卫生, 2015,31(11):1513-1516. doi: 10.11847/zgggws2015-31-11-44. doi: 10.11847/zgggws2015-31-11-44
[2]	Feinstein AR. The pre-therapeutic classification of co-morbidity in chronic disease. J Chronic Dis, 1970,23(7):455-468. doi: 10.1016/0021-9681(70)90054-8. doi: 10.1016/0021-9681(70)90054-8 pmid: 26309916
[3]	Meghani SH, Buck HG, Dickson VV, et al. The conceptualization and measurement of comorbidity: a review of the interprofessional discourse. Nurs Res Pract, 2013,2013:192782. doi: 10.1155/2013/192782. doi: 10.1155/2013/192782
[4]	World Health Organization. The world health report 2008: primary health care now more than ever. Geneva: World Health Organization, 2008.
[5]	Kessler RC, Avenevoli S, McLaughlin KA, et al. Lifetime co-morbidity of DSM-Ⅳ disorders in the US National Comorbidity Survey Replication Adolescent Supplement (NCS-A). Psychol Med, 2012,42(9):1997-2010. doi: 10.1017/S0033291712000025. doi: 10.1017/S0033291712000025 pmid: 22273480
[6]	潘晓鸥, 陈文忠. 结核病与精神障碍共病的相关因素浅探. 中华临床医师杂志(电子版), 2016,10(13):2005-2009. doi: 10.3877/cma.j.issn.1674-0785.2016.13.035. doi: 10.3877/cma.j.issn.1674-0785.2016.13.035
[7]	国家感染性疾病临床医学研究中心, 深圳市第三人民医院, 国家代谢性疾病临床医学研究中心, 等. 结核病与糖尿病共病的治疗管理专家共识. 中国防痨杂志, 2021,43(1):12-22. doi: 10.3969/j.issn.1000-6621.2021.01.004. doi: 10.3969/j.issn.1000-6621.2021.01.004
[8]	蒲莉蓉, 王敏, 李志雄, 等. 边缘型人格障碍与精神疾病共病的研究进展. 中国神经精神疾病杂志, 2019,45(4):250-253. doi: 10.3969/j.issn.1002-0152.2019.04.015. doi: 10.3969/j.issn.1002-0152.2019.04.015
[9]	van Weel C, Schellevis FG. Comorbidity and guidelines: conflicting interests. Lancet, 2006,367(9510):550-551. doi: 10.1016/S0140-6736(06)68198-1. doi: 10.1016/S0140-6736(06)68198-1 URL
[10]	常峰, 张冉, 路云, 等. 共病概念体系研究分析与设计. 中国全科医学, 2018,21(3):256-260. doi: 10.3969/j.issn.1007-9572.2017.00.219. doi: 10.3969/j.issn.1007-9572.2017.00.219
[11]	崔瑶, 刘谦, 秦明照. 老年共病现状及管理策略. 中国全科医学, 2017,20(23):2816-2819. doi: 10.3969/j.issn.1007-9572.2017.06.y54. doi: 10.3969/j.issn.1007-9572.2017.06.y54
[12]	Guiding principles for the care of older adults with multimorbidity: an approach for clinicians. Guiding principles for the care of older adults with multimorbidity: an approach for clinicians: American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity. J Am Geriatr Soc, 2012,60(10):E1-E25. doi: 10.1111/j.1532-5415.2012.04188.x. doi: 10.1111/j.1532-5415.2012.04188.x URL
[13]	颜俊娴, 路云. 英国共病管理政策对我国的启示. 现代商贸工业, 2018, (6):66-68. doi: 10.19311/j.cnki.1672-3198.2018.06.028. doi: 10.19311/j.cnki.1672-3198.2018.06.028
[14]	李凌江, 马辛. 中国抑郁障碍防治指南. 2版. 北京: 中华医学电子音像出版社, 2015: 56-67.
[15]	王姣锋, 张紫欢, 崔月, 等. 上海部分社区老年人共病患病模式及其影响因素分析. 老年医学与保健, 2017,23(2):97-101. doi: 10.3969/j.issn.1008-8296.2017.02.011. doi: 10.3969/j.issn.1008-8296.2017.02.011
[16]	路云, 颜俊娴, 华娟. 老年人共病管理的研究现状及经验探究. 卫生经济研究, 2017, (7):58-61.
[17]	邹月娟, 何平. 老年共病现状及管理的发展趋势. 世界最新医学信息文摘(连续型电子期刊), 2018,18(98):77-78, 81. doi: 10.19613/j.cnki.1671-3141.2018.98.032. doi: 10.19613/j.cnki.1671-3141.2018.98.032
[18]	Siddiqi K, Stubbs B, Lin Y, et al. TB multimorbidity: a global health challenge demanding urgent attention. Int J Tuberc Lung Dis, 2021,25(2):87-90. doi: 10.5588/ijtld.20.0751. doi: 10.5588/ijtld.20.0751 URL
[19]	Reis-Santos B, Gomes T, Macedo LR, et al. Prevalence and patterns of multimorbidity among tuberculosis patients in Brazil: a cross-sectional study. Int J Equity Health, 2013,12:61. doi: 10.1186/1475-9276-12-61. doi: 10.1186/1475-9276-12-61 pmid: 23962018
[20]	Oni T, Youngblood E, Boulle A, et al. Patterns of HIV, TB, and non-communicable disease multi-morbidity in peri-urban South Africa-a cross sectional study. BMC Infect Dis, 2015,15:20. doi: 10.1186/s12879-015-0750-1. doi: 10.1186/s12879-015-0750-1 URL
[21]	Valenzuela-Jiménez H, Manrique-Hernández EF, Idrovo AJ. Association of tuberculosis with multimorbidity and social networks. J Bras Pneumol, 2017,43(1):51-53. doi: 10.1590/S1806-37562016000000075. doi: S1806-37132017000100051 pmid: 28125153
[22]	Kang W, Du J, Yang S, et al. The prevalence and risks of major comorbidities among inpatients with pulmonary tuberculosis in China from a gender and age perspective: a large-scale multicenter observational study. Eur J Clin Microbiol Infect Dis, 2020,40(4):787-800. doi: 10.1007/s10096-020-04077-2. doi: 10.1007/s10096-020-04077-2 URL
[23]	任坦坦, 陆普选, 邓国防, 等. 2020 WHO全球结核报告: 全球与中国关键数据分析. 新发传染病电子杂志, 2020,5(4):280-284. doi: 10.19871/j.cnki.xfcrbzz.2020.04.015. doi: 10.19871/j.cnki.xfcrbzz.2020.04.015
[24]	袁婧, 刘俊, 金永梅, 等. 合并艾滋病的结核病患者血液结核分枝杆菌培养阳性率影响因素的分析. 临床肺科杂志, 2018,23(7):1175-1178. doi: 10.3969/j.issn.1009-6663.2018.07.004. doi: 10.3969/j.issn.1009-6663.2018.07.004
[25]	何华伟, 卢祥婵, 黄爱春, 等. 利福布汀联合抗病毒药物治疗艾滋病合并结核病的临床研究. 河北医学, 2018,24(10):1743-1747. doi: 10.3969/j.issn.1006-6233.2018.10.039. doi: 10.3969/j.issn.1006-6233.2018.10.039
[26]	Lee MR, Huang YP, Kuo YT, et al. Diabetes Mellitus and Latent Tuberculosis Infection: A Systematic Review and Meta analysis. Clin Infect Dis, 2017,64(6):719-727. doi: 10.1093/cid/ciw836. doi: 10.1093/cid/ciw836
[27]	桂徐蔚, 沙巍. 肺结核合并糖尿病研究进展. 中国实用内科杂志, 2015,35(8):657-660. doi: 10.7504/nk2015070107. doi: 10.7504/nk2015070107
[28]	Pan SC, Ku CC, Kao D, et al. Effect of diabetes on tuberculosis control in 13 countries with high tuberculosis: a modelling study. Lancet Diabetes Endocrinol, 2015,3(5):323-330. doi: 10.1016/S2213-8587(15)00042-X. doi: 10.1016/S2213-8587(15)00042-X URL
[29]	Yoon J, Zulman D, Scott JY, et al. Costs associated with multimorbidity among VA patients. Med Care, 2014, 52 Suppl 3(Suppl 3): S31-S36. doi: 10.1097/MLR.0000000000000061. doi: 10.1097/MLR.0000000000000061 URL
[30]	Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med, 2002,162(20):2269-2276. doi: 10.1001/archinte.162.20.2269. doi: 10.1001/archinte.162.20.2269 URL
[31]	Bates M, Marais BJ, Zumla A. Tuberculosis Comorbidity with Communicable and Noncommunicable Diseases. Cold Spring Harb Perspect Med, 2015,5(11):a017889. doi: 10.1101/cshperspect.a017889. doi: 10.1101/cshperspect.a017889 URL
[32]	中华医学会感染病学分会艾滋病学组, 中华医学会热带病与寄生虫学分会艾滋病学组. HIV合并结核分枝杆菌感染诊治专家共识. 中华临床感染病杂志, 2017,10(2):81-90.
[33]	Lin Y, Harries AD, Kumar AMV, et al. Management of diabetes mellitus-tuberculosis: a guide to the essential practice. Paris: International Union Against Tuberculosis and Lung Disease, 2019: 17.